Next Article in Journal
Primary Small Cell Carcinoma of the Kidney: Disease Characteristics and Treatment Outcomes
Previous Article in Journal
Risk Factors, Clinical Characteristics, and Prognosis of Acute Kidney Injury in Hospitalized COVID-19 Patients: A Retrospective Cohort Study
Open AccessCase Report

Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report

1
Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni—15, 40138 Bologna, Italy
2
Maria Cecilia Hospital, Cotignola (RA), 48033 Ravenna, Italy
3
Medical Oncology Department, Bellaria Hospital, Azienda USL of Bologna, Via Altura n.3, 40139 Bologna, Italy
4
Oncology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Sant’Orsola-Malpighi Hospital, University of Bologna, 40138 Bologna, Italy
*
Author to whom correspondence should be addressed.
Received: 8 December 2020 / Revised: 7 January 2021 / Accepted: 8 January 2021 / Published: 11 January 2021
Renal cell carcinoma is a malignant tumor that arises in the kidney parenchyma. For many years, sunitinib has represented the mainstay of medical treatment for metastatic renal cell carcinoma. Herein, we present the case of a 66-year-old woman with metastatic clear cell renal carcinoma undergoing treatment with sunitinib for two years that developed encephalic leukocytoclastic vasculitis, probably due to a paraneoplastic syndrome. View Full-Text
Keywords: encephalic vasculitis; sunitinib; renal cell carcinoma (RCC); leukocytoclastic vasculitis; paraneoplastic syndrome encephalic vasculitis; sunitinib; renal cell carcinoma (RCC); leukocytoclastic vasculitis; paraneoplastic syndrome
Show Figures

Figure 1

MDPI and ACS Style

Massucci, M.; Mollica, V.; Rizzo, A.; Ventrella, L.; Maggio, I.; Manuzzi, L.; Gatto, L.; Brandi, G.; Massari, F. Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report. Medicines 2021, 8, 5. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines8010005

AMA Style

Massucci M, Mollica V, Rizzo A, Ventrella L, Maggio I, Manuzzi L, Gatto L, Brandi G, Massari F. Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report. Medicines. 2021; 8(1):5. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines8010005

Chicago/Turabian Style

Massucci, Maria; Mollica, Veronica; Rizzo, Alessandro; Ventrella, Laura; Maggio, Ilaria; Manuzzi, Lisa; Gatto, Lidia; Brandi, Giovanni; Massari, Francesco. 2021. "Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report" Medicines 8, no. 1: 5. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines8010005

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop